Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells

Applied and Environmental Microbiology

Volumn 72, Issue 1, 2006, Pages 745-752

  Aires, Karina Araujo ^a,b   Cianciarullo, Aurora Marques ^a   Carneiro, Sylvia Mendes ^a   Villa, Luisa Lina ^c   Boccardo, Enrique ^c   Pérez Martinez, Caspar ^d   Perez Arellano, Isabel ^e   Oliveira, Maria Leonor Sarco ^a   Ho, Paulo Lee ^a,b  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^d INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^e CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; CARCINOGENS; CELLS; ELECTRON MICROSCOPY; PROTEINS; VACCINES;

HUMAN CERVICAL CARCINOMA; IMMUNOSORBENT ASSAYS; MUCOSAL PROPHYLACTIC VACCINES; VIRUS-LIKE PARTICLES (VLP);

VIRUSES;

ANTIBODY; CAPSID PROTEIN; EPITOPE; LACTOSE; LIVE VACCINE; UNCLASSIFIED DRUG; VIRUS PROTEIN L1; L1 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; VIRUS ANTIBODY; VIRUS VACCINE;

BIOASSAY; CANCER; CARCINOGEN; MORTALITY; PROTEIN; RECOMBINATION; VACCINE; VIRUS PARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL CELL; CANCER MORTALITY; CAUSE OF DEATH; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOFLUORESCENCE; LACTOBACILLUS CASEI; LACTOSE OPERON; LEPIDOPTERA; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN ASSEMBLY; PROTEIN CONFORMATION; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; VIRUS PARTICLE; WESTERN BLOTTING; ANIMAL; ARMYWORM; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; GENETIC RECOMBINATION; GENETICS; HUMAN; IMMUNIZATION; IMMUNOLOGY; METABOLISM; OPERON; VIRION;

ANIMALIA; BACTERIA (MICROORGANISMS); HUMAN PAPILLOMAVIRUS TYPE 16; LACTOBACILLUS; LACTOBACILLUS CASEI; LEPIDOPTERA; MIRIDAE; SPODOPTERA FRUGIPERDA;

ANIMALS; ANTIBODIES, VIRAL; CAPSID PROTEINS; CELLS, CULTURED; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNIZATION; LACTOBACILLUS CASEI; LACTOSE; MICE; MICE, INBRED BALB C; ONCOGENE PROTEINS, VIRAL; OPERON; PROMOTER REGIONS (GENETICS); PROTEIN CONFORMATION; RECOMBINATION, GENETIC; SPODOPTERA; VIRAL VACCINES; VIRION;

EID: 33644864365     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.72.1.745-752.2006     Document Type: Article

References (44)

1. Arêas, A. P. M., M. L. S. Oliveira, E. N. Miyaji, L. C. C. Leite, K. A. Aires, W. O. Dias, and P. L. Ho. 2004. Expression and characterization of cholera toxin B-pneumococcal surface adhesin A fusion protein in Escherichia coli: ability of CTB-PsaA to induce humoral immune response in mice. Biochem. Biophys. Res. Comm. 321:192-196.
2. Baneyx, F., and M. Mujacic. 2004. Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 22:1399-1408.
3. Bermudez-Humaran, L. G., P. Langella, A. Miyoshi, A. Gruss, R, T. Guerra, R. Montes de Oca-Luna, and Y. Le Loir. 2002. Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Appl. Environ. Microbiol. 68:917-922.
4. Bermudez-Humaran, L. G., P. Langella, N. G. Cortes-Perez, A. Gruss, R. Tamez-Guerra, S. C. Oliveira, O. Saucedo-Cardenas, R. Montes de Oca-Luna, and Y. Le Loir. 2003. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production. Infect. Immun. 71:1887-1896.
5. Bolhuis, A., G. Venema, W. J. Quax, S. Bron, and J. M. Van Dijl. 1999. Functional analysis of paralogous thiol-disulfide oxidoreductases in Bacillus subtilis. J. Biol. Chem. 274:24531-24538.
6. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
7. Carter, J. J., G. C. Wipf, S. F. Benki, N. D. Christensen, and D. A. Galloway. 2003. Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1. J. Virol. 77:11625-11632.
8. Chen, X. S., R. L. Garcea, I. Goldberg, G. Casini, and S. C. Harrison. 2000. Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol. Cell 5:557-567.
9. Chen, X. S., G. Casini, S. C. Harrison, and R. L. Garcea. 2001. Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1. J. Mol. Biol. 307:173-182.
10. Christensen, N. D., J. Dillner, C. Eklund, J. J. Carter, G. C. Wipf, C. A. Reed, N. M. Cladel, and D. A. Galloway. 1996. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 223:174-184.
11. Gosalbes, M. J., I. Pérez-Arellano, C. D. Esteban, J. L. Galán, and G. Pérez-Martínez. 2001. Use of lac regulatory elements for gene expression in Lactobacillus casei. Lait 81:29-35.
12. Grangette, C., H. Muller-Alouf, D. Goudercourt, M. C. Geoffroy, M. Turneer, and A. Mercenier. 2001. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum. Infect. Immun. 69:1547-1553.
13. Harper, D. M., E. L. Franco, C. Wheeler, D. G. Ferris, D. Jenkins, A. Schuind, T. Zahaf, B. Innis, P. Naud, N. S. De Carvalho, C. M. Roteli-Martins, J. Teixeira, M. M. Blatter, A. P. Korn, W. Quint, G. Dubin, and GlaxoSmithKline HPV Vaccine Study Group. 2004. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364:1757-1765.
14. Ishihara, T., H. Tomita, Y. Hasegawa, N. Tsukagoshi, H. Yamagata, and S. Udaka. 1995. Cloning and characterization of the gene for a protein thiol-disulfide oxidoreductase in Bacillus brevis. J. Bacteriol. 177:745-749.
15. Ishii, Y., K. Tanaka, and T. Kanda. 2003. Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids. Virology 308:128-136.
16. Jeong, K. J., and S. Y. Lee. 2003. Enhanced production of recombinant proteins in Escherichia coli by filamentation suppression. Appl. Environ. Microbiol. 69:1295-1298.
17. Kirnbauer, R., J. Taub, H. Greenstone, R. Roden, M. Durst, L. Gissmann, D. R. Lowy, and J. T. Schiller. 1993. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. J. Virol. 67:6929-6936.
18. Koutsky, L. A., K. A. Ault, C. M. Wheeler, D. R. Brown, E. Barr, F. B. Alvarez, L. M. Chiacchierini, and K. U. Jansen. 2002. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 52:743-749.
19. Le Cann, P., P. Coursaget, S. Iochmann, and A. Touze. 1994. Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol. Lett. 117:269-274.
20. Lemay, M. J., N. Rodrigue, C. Gariepy, and L. Saucier. 2000 Adaptation of Lactobacillus alimentarius to environmental stresses. Int. J. Food Microbiol. 55:249-253.
21. Li, M., T. P. Cripe, P. A. Estes, M. K. Lyon, R. C. Rose, and R. L. Garcea. 1997. Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. J. Virol. 71:2988-2995.
22. Maassen, C. B., C. van Holten-Neelen, F. Balk, M. J. den Bak-Glashouwer, R. J. Leer, J. D. Laman, W. J. Boersma, and E. Claassen. 2000. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine 18:2613-2623.
23. McCarthy, M. P., W. I. White, F. Palmer-Hill, S. Koenig, and J. A. Suzich. 1998. Quantitative disassembly and reassembly of human papillomavirus type 11 virus-like particles in vitro. J. Virol. 72:32-41.
24. Medaglini, D., C. M. Rush, P. Sestini, and G. Pozzi. 1997. Commensal bacteria as vectors for mucosal vaccines against sexually transmitted diseases: vaginal colonization with recombinant streptococci induces local and systemic antibodies in mice. Vaccine 15:1330-1337.
25. Morikawa, Y., G. Toshiyuki, and F. Momose. 2004. Human immunodeficiency virus type 1 Gag assembly through assembly intermediates. J. Biol. Chem. 279:31964-31972.
26. Nardelli-Haefliger, D., R. B. Roden, J. Benyacoub, R. Sahli, J. P. Kraehenbuhl, J. T. Schiller, P. Lachat, A. Potts, and P. De Grandi. 1997. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 65:3328-3336.
27. Nilsson, B., C. Berman-Marks, I. D. Kuntz, and S. Anderson. 1991. Secretion incompetence of bovine pancreatic trypsin inhibitor expressed in Escherichia coli. J. Biol. Chem. 266:2970-2977.
28. Oliveira, M. L., V. Monedero, E. N. Miyaji, L. C. Leite, P. L. Ho, and G. Perez-Martinez. 2003. Expression of Streptococcus pneumonias antigens, PsaA (pneumococcal surface antigen A) and PspA (pneumococcal surface protein A) by Lactobacillus casei. FEMS Microbiol. Lett. 227:25-31.
29. Palumbo, E., C. F. Favier, M. Deghorain, P. S. Cocconcelli, C. Grangette, A. Mercenier, E. E. Vaughan. and P. Hols. 2004. Knockout of the alanine racemase gene in Lactobacillus plantarum results in septation defects and cell wall perforation. FEMS Microbiol. Lett. 233:131-138.
30. Parkin, D. M., P. Pisani, and J. Ferlay. 1999. Estimates of the worldwide incidence of 25 major cancers in 1990. Int. J. Cancer 80:827-841.
31. Perdigón, G., E. Vintini, S. Alvarez, M. Medina, and M. Medici. 1999. Study of the possible mechanisms involved in the mucosal immune system activation by lactic acid bacteria. J. Dairy Sci. 82:1108-1114.
32. Posno, M., R. J. Leer, N. van Luijk, M. J. F. van Giezen, P. T. H. M. Heuvelmans, B. C. Lokman, and P. H. Pouwels. 1991. Incompatibility of Lactobacillus vectors with replicons derived from small cryptic Lactobacillus plasmids and segregational instability of the introduced vectors. Appl. Environ. Microbiol. 57:1822-1828.
33. Pouwels, P. H., R. J. Leer, M. Shaw, M. J. Heijne den Bak-Glashouwer, F. D. Tielen, E. Smit, B. Martinez, J. Jore, and P. L. Conway. 1998. Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int. J. Food Microbiol. 41:155-167.
34. Préville, X., D. Ladant, B. Timmerman, and C. Leclerc. 2005. Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein. Cancer Res. 65:641-649.
35. Reuter, J. D., B. E. Vivas-Gonzalez, D. Gomez, J. H. Wilson, J. L. Brandsma, H. L. Greenstone, J. K. Rose, and A. Roberts. 2003. Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced diseases. J. Virol. 76:8900-8909.
36. Roden, R., and L. Morris. 2004. Vaccination to prevent and treat cervical cancer. Hum. Pathol. 35:971-982.
37. Sasagawa, T., P. Pushko, G. Steers, S. E. Gschmeissner, M. A. Hajibagheri, J. Finch, L. Crawford, and M. Tommasino. 1995. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology 206:126-135.
38. Suzich, J. A., S. J. Ghim, F. J. Palmer-Hill, W. I. White, J. K. Tamura, J. A. Bell, J. A. Newsome, A. B. Jenson, and R. Schlegel. 1995. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557.
39. Tobery, T. W., J. F. Smith, N. Kuklin, D. Skulsky, C. Ackerson, L. Huang, L. Chen, J. C. Cook, W. L. McClements, and K. U. Jansen. 2003. Effect of vaccine delivery system on the induction of HPV16 L1-specific humoral and cell-mediated immune responses in immunized rhesus macaques. Vaccine 21:1539-1547.
40. Villa, L. L., R. L. R. Costa, C. A. Petta, R. P. Andrade, K. A. Ault, A. R. Giuliano, C. M. Wheeler, L. A. Koutsky, C. Malm, M. Lehtinen, F. E. Skjeldestad, S. E. Olsson, M. Steinwall, D. R. Brown, R. J. Kurman, B. M. Ronnett, M. H. Stoler, A. Ferenczy, D. M. Harper, G. M. Tamms, J. Yu, L. Lupinacci, R. Railkar, F. J. Taddeo, K. U. Jansen, M. T. Esser, H. L. Sings, A. J. Saah, and E. Barr. 2005. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6:271-278.
41. Xin, K. Q., Y. Hoshino, Y. Toda, S. Igimi, Y. Kojima, N. Jounai, K. Ohba, A. Kushiro, M. Kiwaki, K. Hamajima, D. Klinman, and K. Okuda. 2003. Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102:223-228.
42. Wang, Z., N. Christensen, J. T. Shiller, and J. Dillner. 1997. A monoclonal antibody against human papillomavirus type 16 capsids blocks the serological reactivity of most human sera. J. Gen. Virol. 78:2209-2215.
43. White, W. I., S. D. Wilson, F. J. Palmer-Hill, R. M. Woods, S. J. Ghim, L. A. Hewitt, D. M. Goldman, S. J. Burke, A. B. Jenson, S. Koenig, and J. A. Suzich. 1999. Characterization of a major neutralizing epitope on human papillomavirus type 16 L1. J. Virol. 73:4882-4889.
44. Zhang, W., J. Carmichael, J. Ferguson, S. Inglis, H. Ashrafian, and M. Stanley. 1998. Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation and self-assembly of virus-like particles in vitro. Virology 243:423-431.